Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy

Toll-like receptors (TLRs) have first been characterized for their capacity to detect conserved microbial components like lipopolysaccharide (LPS) and double-stranded RNA, resulting in the elicitation of potent (innate) immune responses against invading pathogens. More recently, TLRs have also been...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Vacchelli, Erika, Galluzzi, Lorenzo, Eggermont, Alexander, Fridman, Wolf Hervé, Galon, Jerome, Sautès-Fridman, Catherine, Tartour, Eric, Zitvogel, Laurence, Kroemer, Guido
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Landes Bioscience 2012
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3489745/
https://ncbi.nlm.nih.gov/pubmed/23162757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.20931
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak